Patent · US Active

CRISPR RNA targeting enzymes and systems and uses thereof

US10392616B2 · kind B2 · utility

15Cited by
0References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2018
Grant dateAug 27, 2019
Priority date
Expiry dateMar 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.